URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Anton Porsteinsson

Concepts (212)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Alzheimer Disease
31
1997
289
4.910
Why?
Dementia
8
1997
100
2.690
Why?
Valproic Acid
9
1997
54
2.140
Why?
Psychomotor Agitation
9
1997
43
1.700
Why?
Mental Disorders
7
1996
346
1.440
Why?
Amyloid beta-Peptides
4
2011
56
1.250
Why?
Memantine
2
2007
14
1.220
Why?
Excitatory Amino Acid Antagonists
2
2007
40
1.200
Why?
Receptors, N-Methyl-D-Aspartate
3
2003
87
1.200
Why?
Aged
38
1996
7272
1.070
Why?
Cholinesterase Inhibitors
5
2000
20
1.060
Why?
Serotonin Uptake Inhibitors
6
2002
35
1.030
Why?
Cognition Disorders
8
2008
278
1.000
Why?
Aging
2
2009
706
0.960
Why?
Peptide Fragments
3
2011
301
0.940
Why?
Sertraline
5
2006
9
0.930
Why?
Neuropsychological Tests
8
2000
375
0.890
Why?
Depressive Disorder, Major
3
1997
164
0.810
Why?
Aged, 80 and over
20
1996
2513
0.720
Why?
Psychotropic Drugs
4
1997
38
0.710
Why?
Double-Blind Method
14
2000
998
0.690
Why?
Depression
7
2001
431
0.560
Why?
Humans
43
1996
36400
0.530
Why?
Female
31
1996
19826
0.520
Why?
Male
30
1996
19713
0.490
Why?
Neuroprotective Agents
5
2002
125
0.470
Why?
Depressive Disorder
4
2006
321
0.440
Why?
Antimanic Agents
2
2001
8
0.420
Why?
Enzyme Inhibitors
2
2003
438
0.420
Why?
Antibodies, Monoclonal, Humanized
2
2012
89
0.410
Why?
Severity of Illness Index
5
2000
919
0.400
Why?
Psychotic Disorders
3
2003
66
0.380
Why?
Activities of Daily Living
4
2000
255
0.360
Why?
Treatment Outcome
12
2000
2623
0.360
Why?
Antidepressive Agents
2
2010
93
0.360
Why?
Drug Therapy, Combination
3
1997
390
0.350
Why?
Anticonvulsants
4
2001
120
0.340
Why?
Mental Status Schedule
5
2005
32
0.330
Why?
Cognition
3
2000
227
0.320
Why?
Middle Aged
14
1996
9877
0.320
Why?
Dose-Response Relationship, Drug
6
2000
1138
0.310
Why?
Antipsychotic Agents
4
2003
116
0.310
Why?
GABA Agents
1
1997
1
0.300
Why?
Street Drugs
1
1997
19
0.290
Why?
Alcoholism
1
1997
95
0.270
Why?
Psychiatric Status Rating Scales
6
2005
333
0.250
Why?
Substance-Related Disorders
1
1997
207
0.240
Why?
Principal Component Analysis
2
2010
31
0.240
Why?
Disease Progression
3
2008
519
0.220
Why?
Citalopram
1
2012
1
0.210
Why?
Behavioral Symptoms
2
2000
15
0.210
Why?
Neuroimaging
1
2012
12
0.210
Why?
Phosphoric Diester Hydrolases
1
2012
56
0.210
Why?
Inositol
1
2011
25
0.200
Why?
Genetic Variation
1
2012
148
0.200
Why?
Platelet Aggregation Inhibitors
1
2011
59
0.200
Why?
Discriminant Analysis
1
2010
22
0.190
Why?
Suicide
1
1997
411
0.190
Why?
Galantamine
1
2000
1
0.190
Why?
Propylamines
1
2009
7
0.180
Why?
Adrenergic Uptake Inhibitors
1
2009
22
0.180
Why?
Brain
3
2011
1221
0.180
Why?
Spiro Compounds
1
2008
5
0.170
Why?
Prospective Studies
3
2005
1677
0.170
Why?
Diabetes Complications
1
2009
66
0.170
Why?
Brief Psychiatric Rating Scale
2
2003
11
0.160
Why?
Naproxen
1
2008
4
0.160
Why?
Quinolones
1
2008
27
0.160
Why?
Risk Factors
6
1997
2318
0.160
Why?
Follow-Up Studies
5
2006
1857
0.160
Why?
Indoles
1
2008
104
0.160
Why?
Pyrazoles
1
2008
59
0.160
Why?
Piperazines
1
2008
76
0.150
Why?
Sulfonamides
1
2008
103
0.150
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2008
94
0.150
Why?
Antidepressive Agents, Second-Generation
1
2006
14
0.150
Why?
Clinical Trials as Topic
3
2001
675
0.140
Why?
Caregivers
2
2003
75
0.140
Why?
Azepines
1
2006
10
0.140
Why?
Alanine
1
2006
93
0.140
Why?
Endopeptidases
1
2006
57
0.130
Why?
Placebos
4
2001
182
0.130
Why?
Psychoanalytic Interpretation
1
2005
5
0.130
Why?
Obesity
1
2009
335
0.130
Why?
Proportional Hazards Models
3
2009
453
0.120
Why?
Social Control, Formal
1
2003
10
0.120
Why?
Long-Term Care
1
2003
64
0.110
Why?
Benzodiazepines
1
2002
26
0.110
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2002
51
0.110
Why?
Magnetic Resonance Imaging
3
2011
1010
0.100
Why?
Apolipoprotein E4
2
2009
6
0.100
Why?
Time Factors
4
2001
3201
0.090
Why?
Genotype
2
2011
487
0.090
Why?
Calcium
1
2007
1127
0.090
Why?
Statistics, Nonparametric
1
2001
256
0.090
Why?
Educational Status
2
2010
172
0.090
Why?
Regression Analysis
1
2001
524
0.080
Why?
Outcome Assessment (Health Care)
2
2011
293
0.080
Why?
Epilepsy
1
2001
161
0.080
Why?
Patient Dropouts
2
2006
28
0.080
Why?
Analysis of Variance
1
2001
725
0.080
Why?
Questionnaires
1
2003
998
0.080
Why?
Neurotransmitter Agents
1
1997
46
0.080
Why?
Longitudinal Studies
2
2008
390
0.070
Why?
Thyroid Function Tests
1
1996
15
0.070
Why?
Thyrotropin
1
1996
32
0.070
Why?
Reproducibility of Results
2
2010
884
0.070
Why?
Cause of Death
1
1997
159
0.070
Why?
Patient Care Team
1
1997
194
0.060
Why?
Geriatric Assessment
2
2001
150
0.060
Why?
Comorbidity
1
1997
374
0.060
Why?
Randomized Controlled Trials as Topic
2
2001
409
0.060
Why?
Nursing Homes
2
2005
192
0.060
Why?
Retrospective Studies
2
2009
2260
0.060
Why?
Mood Disorders
2
2002
61
0.060
Why?
Social Support
2
2003
228
0.060
Why?
Signal Transduction
1
2002
1626
0.050
Why?
Age Factors
2
2001
1121
0.050
Why?
New York
1
1997
1282
0.050
Why?
Genome-Wide Association Study
1
2012
23
0.050
Why?
Tomography, Emission-Computed, Single-Photon
1
2012
72
0.050
Why?
Adult
3
1996
11345
0.050
Why?
Cognitive Therapy
1
2012
40
0.050
Why?
Pyridines
1
2012
84
0.050
Why?
Genomics
1
2012
48
0.050
Why?
Atrophy
1
2011
67
0.050
Why?
Electroencephalography
1
2012
177
0.050
Why?
Polymorphism, Single Nucleotide
1
2012
84
0.050
Why?
Models, Genetic
1
2012
160
0.050
Why?
Multicenter Studies as Topic
1
2011
128
0.050
Why?
Diagnostic Imaging
1
2012
86
0.050
Why?
Adolescent
3
1996
4752
0.050
Why?
Stroop Test
1
2010
2
0.050
Why?
Word Association Tests
1
2010
4
0.050
Why?
Trail Making Test
1
2010
7
0.050
Why?
Apathy
1
2010
1
0.050
Why?
Administration, Oral
1
2011
309
0.050
Why?
Delusions
1
2010
7
0.050
Why?
Verbal Behavior
1
2010
27
0.050
Why?
Hallucinations
1
2010
13
0.050
Why?
Reading
1
2010
20
0.050
Why?
Brain Mapping
1
2012
205
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
466
0.050
Why?
Diagnostic and Statistical Manual of Mental Disorders
1
2010
40
0.050
Why?
Cross-Cultural Comparison
1
2010
33
0.050
Why?
Polymorphism, Genetic
1
2011
199
0.050
Why?
Visual Cortex
1
2012
126
0.050
Why?
Observer Variation
1
2010
143
0.050
Why?
Medication Adherence
1
2010
21
0.040
Why?
Statistics as Topic
1
2010
187
0.040
Why?
Memory
1
2010
102
0.040
Why?
PubMed
1
2009
1
0.040
Why?
Space Perception
1
2010
84
0.040
Why?
Body Weight
1
2000
338
0.040
Why?
Overweight
1
2009
36
0.040
Why?
Psychometrics
1
2010
221
0.040
Why?
Patient Compliance
1
2010
171
0.040
Why?
Drug Toxicity
1
2008
16
0.040
Why?
Animals
2
2002
16270
0.040
Why?
Chi-Square Distribution
1
2010
333
0.040
Why?
Multivariate Analysis
1
2010
531
0.040
Why?
Cohort Studies
1
2012
969
0.040
Why?
Predictive Value of Tests
1
2010
601
0.040
Why?
Confidence Intervals
1
2008
165
0.040
Why?
Body Mass Index
1
2009
211
0.040
Why?
United States
2
2003
2630
0.040
Why?
Insulin-Like Growth Factor I
1
2008
106
0.040
Why?
Sex Factors
1
2010
584
0.040
Why?
Saccharomyces cerevisiae
1
2012
384
0.040
Why?
Communication
1
2010
271
0.040
Why?
Prognosis
1
2010
1080
0.040
Why?
Glucose
1
2009
400
0.040
Why?
Problem Solving
1
2006
44
0.040
Why?
Affect
1
2006
78
0.040
Why?
Counseling
1
2006
70
0.040
Why?
Amyloid Precursor Protein Secretases
1
2006
12
0.030
Why?
Aspartic Acid Endopeptidases
1
2006
20
0.030
Why?
Outpatients
1
2005
32
0.030
Why?
Cost of Illness
1
2006
74
0.030
Why?
Quality of Life
1
2010
509
0.030
Why?
Insulin
1
2009
670
0.030
Why?
Quality Assurance, Health Care
1
2006
119
0.030
Why?
Homes for the Aged
1
2005
60
0.030
Why?
Combined Modality Therapy
1
2006
486
0.030
Why?
Primary Health Care
1
2010
492
0.030
Why?
Clinical Protocols
1
2005
105
0.030
Why?
Drug Administration Schedule
1
2005
369
0.030
Why?
Research Design
1
2006
333
0.030
Why?
Pilot Projects
1
2005
441
0.030
Why?
Ginkgo biloba
1
2003
3
0.030
Why?
Homocysteine
1
2003
28
0.030
Why?
Drug Evaluation
1
2003
101
0.030
Why?
Plant Extracts
1
2003
21
0.030
Why?
Phytotherapy
1
2003
18
0.030
Why?
Professional-Family Relations
1
2003
62
0.030
Why?
Vitamin E
1
2003
89
0.030
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2003
48
0.030
Why?
Child, Preschool
2
1996
2612
0.030
Why?
Anti-Inflammatory Agents
1
2003
116
0.030
Why?
Diagnosis, Differential
1
2005
878
0.030
Why?
Decision Making
1
2003
224
0.020
Why?
Sleep Disorders
1
2001
70
0.020
Why?
Child
2
1996
4086
0.020
Why?
Research
1
2001
179
0.020
Why?
Patient Selection
1
2001
209
0.020
Why?
Thyroxine
1
1996
46
0.020
Why?
Thyroid Diseases
1
1996
20
0.020
Why?
Triiodothyronine
1
1996
49
0.020
Why?
Cost-Benefit Analysis
1
1996
209
0.020
Why?
Infant
1
2001
2249
0.020
Why?
Mass Screening
1
1996
252
0.010
Why?
Hospitalization
1
1996
377
0.010
Why?

Visualizations


Porsteinsson's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department